MyMetabolon Login
© 2020 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Microbiome
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Is the Fountain of Youth a Metabolite Away?

inBiomarkers, Drug Development

The media touts a new stay-young regimen every day, such as caloric restriction (equal to starvation for a food lover like me) or the consumption of red wine (a more palatable undertaking). The truth is, aging is astoundingly complex and is influenced by our diet, environment, genetics and the microbiome within us.

by Kirk Beebe

Having just celebrated another birthday, I really started thinking about how to slow my descent “over the hill.” The algorithms driving social media apparently know this, too, as I am frequently served unsolicited ads for “over 40,” “anti-aging,” or “muscle-building supplements.”

Although these advertisements have superficial appeal, as a scientist, I prefer solutions grounded in data. I believe that if we truly understand the details of a biological process, we may be able to derive specific strategies for improving life or health span.

The media touts a new stay-young regimen every day, such as caloric restriction (equal to starvation for a food lover like me) or the consumption of red wine (a more palatable undertaking). The truth is, aging is astoundingly complex and is influenced by our diet, environment, genetics and the microbiome within us.

Science is beginning to lay a pretty compelling trail of breadcrumbs about the processes behind aging, and metabolomics and other clinical and biological measures may forge new paths toward wellness and longevity.

While primary research continues to pour out each month, these “breadcrumbs” are consolidated nicely in several recent reviews. Fontana and colleagues1 focused on the dietary or interventional angles that are emerging, and a review by de Cabo et al2. boldly took a stance on the lifestyle, pharmacological and molecular themes that appear to be the most viable lines of pursuit for aging research. This is precisely the type of information I am looking for in my personal quest to stay young.

If their review was a 10,000-foot view and I elevate that to 30,000 feet, a target becomes clear:  management of nutrients and their metabolism, chiefly by the mitochondria. As the metabolic hub of our cells, mitochondria have been a focus of aging research for decades and are investigated intensely in many age-related diseases such as diabetes, cancer and Alzheimer’s. While this is no surprise to many of you, it is often not well appreciated in our gene-centric life sciences world just how integrated mitochondria are to complex cellular function and fate. Just this spring, Sabatini and colleagues3  described how old and young mitochondria are allocated based on specific properties of the daughter cells upon division of stem-like cells.

But, beyond the mitochondria as a whole, researchers are increasingly identifying specific nutrients or metabolites that have important roles in mitochondrial function and aging – things that in theory could serve as elixirs (i.e. supplements) for antiaging. A mitochondrial metabolite called alpha-ketoglutarate was shown to extend longevity in a model of aging4. Another metabolite, NAD, is frequently cited with ties to nutrient regulation, mitochondrial homeostasis, and aging5.  And, even the most-prescribed diabetes drug on the planet that is also a focus of aging research, metformin, was shown to target a mitochondrial enzyme after almost 100 years of clinical use without knowledge of the target6. Finally, “secreted compounds” (likely metabolites) have been described to regulate aging in an animal model7.

Molecules like these offer the seductive possibility that dietary supplements may be a simple solution to repressing the effects of aging. But, after having read numerous reports where diabetes, aging or cancer were reversed in animal models, my commitment to begin such supplementation regimens requires far more validation in humans.

Perhaps the work that Metabolon is doing with newly launched health platforms such as Craig Venter’s Health Nucleus and Lee Hood’s Arivale, which attempt to leverage tools including whole genome sequencing, microbiome analysis and metabolomics to tackle aging-related biological decline, will provide the evidence I seek. I anxiously await the results of these massively ambitious projects before I commit my dollars to a health food store – and potential longevity – to specific supplements.

My bet is that continued investigation into the relationship between the mitochondria and cellular nutrient homeostasis will expose longstanding secrets about aging. In the meantime, I will continue my battle against aging with the basics that nearly everyone agrees are keys to promoting health, if not also longevity:  diet (quality and quantity) combined with regular exercise. And, some red wine…just in case.

For more information see:

  1. Fontana, L. & Partridge, L. Promoting health and longevity through diet: from model organisms to humans. Cell 161, 106-118 (2015).
  2. de Cabo, R., Carmona-Gutierrez, D., Bernier, M., Hall, M.N. & Madeo, F. The search for antiaging interventions: from elixirs to fasting regimens. Cell 157, 1515-1526 (2014).
  3. Katajisto, P. et al. Stem cells. Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness. Science 348, 340-343 (2015).
  4. Chin, R.M. et al. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 510, 397-401 (2014).
  5. Mouchiroud, L. et al. The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell 154, 430-441 (2013).
  6. Madiraju, A.K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542-546 (2014).
  7. Maures, T.J. et al. Males shorten the life span of C. elegans hermaphrodites via secreted compounds. Science 343, 541-544 (2014).
Back to the Blog
  • Using Metabolomics to Reduce Drug Attrition in Pharma R&D
    Previous PostUsing Metabolomics to Reduce Drug Attrition in Pharma R&D
  • Next PostThe Cancer Metabolism Beachhead Expands with Metabolomics
    Using Metabolomics to Reduce Drug Attrition in Pharma R&D

Related Posts

Webinar: Unique advantages of incorporating untargeted and targeted metabolomics in drug development and clinical trials
Events

Webinar: Unique advantages of incorporating untargeted and targeted metabolomics in drug development and clinical trials

Leveraging Machine Learning to Advance Precision Medicine
Press

Leveraging Machine Learning to Advance Precision Medicine

National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study
Company News

National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study

Webinar: Deeper Understanding of COVID-19 Phenotypes Through Metabolomics: A Panel Discussion
Events

Webinar: Deeper Understanding of COVID-19 Phenotypes Through Metabolomics: A Panel Discussion

Metabolon’s Client Data Table enables study analysis
Blog Capabilities Working with Metabolon

Metabolon’s Client Data Table enables study analysis

Establishing industry QA/QC best practices for global metabolomics
Capabilities Working with Metabolon

Establishing industry QA/QC best practices for global metabolomics

Webinar: Mechanisms of Immune Control and Metabolomics
Events

Webinar: Mechanisms of Immune Control and Metabolomics

Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies
Company News

Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies

Event: BioProcess International
Events

Event: BioProcess International

Presentation: Leveraging Global Metabolomics at the Intersection of Physiology and Behavior (at MANA 2020)
Events

Presentation: Leveraging Global Metabolomics at the Intersection of Physiology and Behavior (at MANA 2020)

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2021 Metabolon, Inc. All rights reserved. Privacy & Terms

in
Copy
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.